Suppr超能文献

肌钙蛋白-原肌球蛋白对交联肌动蛋白-肌球蛋白亚片段1的三磷酸腺苷酶活性的调节

Regulation of the adenosinetriphosphatase activity of cross-linked actin-myosin subfragment 1 by troponin-tropomyosin.

作者信息

King R T, Greene L E

出版信息

Biochemistry. 1985 Nov 19;24(24):7009-14. doi: 10.1021/bi00345a039.

Abstract

Chalovich and Eisenberg [Chalovich, J. M., & Eisenberg, E. (1982) J. Biol. Chem. 257, 2432-2437] have suggested that at low ionic strength, troponin-tropomyosin regulates the actomyosin ATPase activity by inhibiting a kinetic step in the actomyosin ATPase cycle rather than by blocking the binding of myosin subfragment 1 (S-1) to actin. This leads to the prediction that troponin-tropomyosin should inhibit the ATPase activity of the complex of actin and S-1 (acto . S-1) even when S-1 is cross-linked to actin. We now find that the ATPase activity of cross-linked actin . S-1 prepared under milder conditions than those used by Mornet et al. [Mornet, D., Bertrand, R., Pantel, P., Audemard, E., & Kassab, R. (1981) Nature (London) 292, 301-306] is inhibited 90% by troponin-tropomyosin in the absence of Ca2+. At mu = 18 mM, 25 degrees C, the ATPase activity of this cross-linked preparation is only about 2-fold greater than the maximal actin-activated ATPase activity of S-1 obtained with regulated actin in the absence of Ca2+. At physiological ionic strength, the ATPase activity of this cross-linked actin . S-1 preparation is inhibited about 95% by troponin-tropomyosin. Since cross-linked S-1 behaves kinetically like S-1 in the presence of infinite actin concentration, it is very unlikely that inhibition of the ATPase activity of cross-linked actin . S-1 is due to blocking of the binding of S-1 to actin. Therefore, these results are in agreement with the suggestion that troponin-tropomyosin regulates primarily by inhibiting a kinetic step in the ATPase cycle.

摘要

查洛维奇和艾森伯格[查洛维奇,J.M.,& 艾森伯格,E.(1982年)《生物化学杂志》257卷,2432 - 2437页]提出,在低离子强度下,肌钙蛋白 - 原肌球蛋白通过抑制肌动球蛋白ATP酶循环中的一个动力学步骤来调节肌动球蛋白ATP酶活性,而不是通过阻止肌球蛋白亚片段1(S - 1)与肌动蛋白的结合。这导致预测,即使S - 1与肌动蛋白交联,肌钙蛋白 - 原肌球蛋白也应抑制肌动蛋白和S - 1复合物(肌动蛋白·S - 1)的ATP酶活性。我们现在发现,在比莫尔内等人[莫尔内,D.,伯特兰,R.,潘特尔,P.,奥德马尔,E.,& 卡萨布,R.(1981年)《自然》(伦敦)292卷,301 - 306页]所采用的条件更温和的情况下制备的交联肌动蛋白·S - 1,在无Ca2 +时,其ATP酶活性被肌钙蛋白 - 原肌球蛋白抑制90%。在μ = 十八毫摩尔、25摄氏度时,这种交联制剂的ATP酶活性仅比在无Ca2 +时用受调节的肌动蛋白获得的S - 1的最大肌动蛋白激活的ATP酶活性大约高2倍。在生理离子强度下,这种交联肌动蛋白·S - 1制剂的ATP酶活性被肌钙蛋白 - 原肌球蛋白抑制约95%。由于交联的S - 1在动力学上的行为类似于在无限肌动蛋白浓度存在下的S - 1,所以交联肌动蛋白·S - 1的ATP酶活性受到抑制极不可能是由于S - 与肌动蛋白结合受阻所致。因此,这些结果与肌钙蛋白 - 原肌球蛋白主要通过抑制ATP酶循环中的一个动力学步骤进行调节的观点一致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验